Moneycontrol
Last Updated : Jan 08, 2018 06:34 PM IST | Source: Moneycontrol.com

Sun Pharma gains 2% as USFDA likely to inspect Halol facility in February

In December 2015, the USFDA had issued a warning letter to Halol unit (Gujarat), which accounts for around 20 percent of US Sales for Sun Pharma.

Sun Pharmaceutical Industries shares closed at Rs 591.60, rising 2.22 percent after sources told CNBC-TV18 that the US Food and Drug Administration is expected to inspect company's Halol facility for 2 weeks.

The re-inspection of plant by the US Food and Drug Administration is likely to begin on February 12 and end on February 23, according to reports.

Sources said the US FDA inspection dates could change on account of technicalities.

In December 2015, the USFDA had issued a warning letter to Halol unit (Gujarat), which accounts for around 20 percent of US Sales for Sun Pharma.

The plant was re-inspected by USFDA in November-December 2016 & issued 9 observations.

Sun Pharma has no comment w.r.t re-inspection of Halol facility.
First Published on Jan 8, 2018 05:45 pm
Loading...
Sections
Follow us on
Available On
PCI DSS Compliant